Strains

EcN-MLH, a targeted intestinal probiotic, colonizes the intestinal flora, releases 750,000 U/g SOD enzyme activity, effectively eliminates free radicals, and demonstrates remarkable efficacy in preventing and treating intestinal inflammation and oxidative stress damage. Additionally, it possesses the ability to specifically adhere to cancer cells. By jointly expressing multiple key tumor suppressor genes (TP53, CIP-KIP, INK4, PTEN), it achieves precise and quantitative release, regulates the cell cycle, and maintains the dynamic balance of cancer cells in the body.

Details